Anna Flora Farago MD, PhD

Anna F. Farago, MD, PhD, is an attending physician in the Center for Thoracic Cancers at Massachusetts General Hospital, an instructor at Harvard Medical School, and a research affiliate at the Koch Institute for Integrative Cancer Research at MIT. Dr. Farago cares for patients with lung cancer and other thoracic malignancies, and also performs clinical and translational research.

Dr. Farago's major research interests include studying small cell lung cancer (SCLC) and other lung neuroendocrine cancers. She works works with preclinical models including genetically engineered mouse models of SCLC in the laboratory of Dr. Tyler Jacks at MIT's Koch Institute for Integrative Cancer Research. She also works to develop new preclinical models of SCLC and performs research through clinical trials. Dr. Farago has been awarded several research grants, including grants from Uniting Against Lung Cancer and the Conquer Cancer Foundation of ASCO/AACR.